Six African countries to get own mRNA jab production
Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia were selected as the first recipients of technology from the WHO’s global mRNA vaccine hub, in a push to ensure Africa can make its own jabs to fight the Covid and other diseases.
“No other event like the Covid-19 pandemic has shown that reliance on a few companies to supply global public goods is limiting, and dangerous,” WHO chief Tedros Adhanom Ghebreyesus said.
“The best way to address health emergencies and reach universal health coverage is to significantly increase the capacity of all regions to manufacture the health products they need.”
Tedros has continually called for equitable access to vaccines in order to beat the pandemic, and rails against the way wealthy nations have hogged doses, leaving Africa lagging behind other continents in the global vaccination effort.
A ceremony marking the mRNA tech transfer announcement was to be held Friday in Brussels at the summit between the European Union and the African Union.
European Commission chief Ursula von der Leyen said: “We have been talking a lot about producing mRNA vaccines in Africa. But this goes even beyond. This is mRNA technology designed in Africa, led by Africa and owned by Africa.”
Currently only one percent of the vaccines used in Africa are produced on the continent of some 1.3 billion people.
The WHO set up a global mRNA technology transfer hub in South Africa last year to support manufacturers in low- and middle-income countries to produce their own vaccines.
The global hub’s role is to ensure that manufacturers in those nations have the know-how to make mRNA vaccines at scale and according to international standards.
As used in the Pfizer/BioNTech and Moderna Covid-19 vaccines, mRNA technology provokes an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells. Read More…